San Francisco Sentry Investment Group’s Adverum Biotechnologies ADVM Stock Holding History

San Francisco Sentry Investment Group’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$1.68M	Hold	48,000	–	–	0.88%	17
2021 Q1	$4.73M	Hold	48,000	–	–	2.02%	6
2020 Q4	$5.2M	Hold	48,000	–	–	2.45%	4
2020 Q3	$4.94M	Hold	48,000	–	–	2.54%	4
2020 Q2	$10M	Hold	48,000	–	–	5.33%	2
2020 Q1	$4.69M	Hold	48,000	–	–	2.97%	5
2019 Q4	$5.53M	Hold	48,000	–	–	2.48%	4
2019 Q3	$2.62M	Hold	48,000	–	–	1.2%	18
2019 Q2	$5.71M	Hold	48,000	–	–	2.62%	3
2019 Q1	$2.52M	Hold	48,000	–	–	1.09%	20
2018 Q4	$1.51M	Hold	48,000	–	–	0.71%	30
2018 Q3	$2.9M	Hold	48,000	–	–	1.09%	19
2018 Q2	$2.54M	Hold	48,000	–	–	1.06%	16
2018 Q1	$2.78M	Hold	48,000	–	–	0.8%	21
2017 Q4	$1.68M	Buy	+48,000	New	+$1.58M	0.49%	40

Other funds holding ADVM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SFI

Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

San Francisco Sentry Investment Group's ADVM Position: Q2 2021 in Review

San Francisco Sentry Investment Group held its Adverum Biotechnologies (ADVM) position steady in Q2 2021 at 48,000 shares worth $1.68M. The position accounts for 0.88% of the portfolio, ranked #17.

San Francisco Sentry Investment Group first reported a position in ADVM in Q4 2017 and has held it in 15 quarters since. The position peaked at $10M in Q2 2020. 118 funds tracked by Wall St. Rank hold ADVM as of Q2 2021.

San Francisco Sentry Investment Group held 48,000 shares of Adverum Biotechnologies worth $1.68M as of Q2 2021.
San Francisco Sentry Investment Group left its Adverum Biotechnologies share count unchanged in Q2 2021.
Adverum Biotechnologies made up 0.88% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #17 holding.
San Francisco Sentry Investment Group first reported a position in Adverum Biotechnologies in Q4 2017 and has held it in 15 quarters since.
San Francisco Sentry Investment Group's Adverum Biotechnologies position peaked at $10M in Q2 2020.
118 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.